ESCHERICHIA COLI STRAIN MARKET ANALYSIS

Escherichia Coli Strain Market, By Strain Type (Commensal strains, Diarrheal strains, Extraintestinal pathogenic strains, Uropathogenic strains, Neonatal meningitis strains, and Others), By Application (Diagnostics, Research, Therapeutics, Production of recombinant proteins, Quality control organisms, and Others), By Pathogenicity (Pathogenic E. coli and Non-pathogenic E. coli), By End User (Research Institutes, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Nov 2023
Code : CMI6132
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Escherichia Coli Strain MarketSize and Trends

The escherichia coli strain market is expected to reach US$ 3.14 Bn by 2030 from US$ 1.97 Bn in 2023; and is expected to exhibit a compound annual growth rate (CAGR) of 6.9% from 2023 to 2030.

The growth of the escherichia coli strain market is due to factors such as increasing E. coli testing, growing product innovations, and rising research activities. On the other hand, testing challenges is the major factor limit the market growth.

Escherichia Coli Strain Market Trends

Advanced genetic engineering techniques: The development and application of advanced genetic engineering techniques, such as CRISPR-Cas9 and synthetic biology tools, have significantly impacted the E. coli strain market. These tools allow researchers to modify E. coli strains more precisely and efficiently, thereby leading to the creation of strains with improved characteristics for various applications.
Rising demand for biopharmaceuticals: The demand for biopharmaceuticals, including therapeutic proteins and antibodies produced using E. coli strains, has been steadily increasing. E. coli remains a popular host for biopharmaceutical production due to its ease of use, scalability, and cost-effectiveness. The market trend involves optimizing E. coli strains for higher protein yields and better post-translational modifications.
Environmental and sustainable solutions: The push for more environmentally friendly and sustainable solutions in various industries has led to increased interest in E. coli strains for bioremediation, biofuel production, and other sustainable applications. E. coli's versatility in metabolizing various feedstocks makes it attractive for these purposes.
Personalized medicine and precision biotechnology: With advancements in genomics and precision medicine, there is a growing trend towards personalized medicine. E. coli strains are being engineered to produce customized therapeutic proteins, vaccines, and other bioactive molecules tailored to individual patients' needs.

Figure 1. Global Escherichia Coli Strain Market Share (%), By Region, 2023